PAINT For IAPT

  • Research type

    Research Study

  • Full title

    Chronic Pain And Insomnia Treatment for IAPT

  • IRAS ID

    311607

  • Contact name

    Nicole Tang

  • Contact email

    n.tang@warwick.ac.uk

  • Sponsor organisation

    University of Warwick

  • Duration of Study in the UK

    2 years, 3 months, 30 days

  • Research summary

    The clinical problem we hope to address with this project is chronic pain, which is pain lasting or recurring for more than 3 months beyond the expected time of healing. Living with chronic pain can be challenging, as the impact of pain impinges on normal life with serious financial and mental health ramifications. Most pain patients presenting at GP surgeries have clinical insomnia that warrants treatment and see sleep as a top treatment priority. Yet, there is not a defined treatment pathway for dealing with insomnia within the context of chronic pain.

    The current study seeks to evaluate – using a mixed methods approach – the feasibility of delivering hybrid CBT for pain and insomnia within IAPT (Improving Access to Psychological Therapies) Pathway for People with Long-term Physical Health Conditions and Medically Unexplained Symptoms provided by NHS services in England by high-intensity (level 3) therapists. The hybrid CBT is based on two NIHR-funded studies completed by the principal investigator’s team developing a hybrid CBT treatment for chronic pain and insomnia in secondary and primary care (Tang et al., 2012, Tang et al., 2020).

    The study has four main components: First, a brief survey with clinical leads of our IAPT partners to establish case prevalence. Second, we will provide training on delivering the hybrid CBT to participating IAPT therapists. Pre-training, we will distribute a short survey to IAPT therapists asking about perceived training needs. Post-training, the therapists will be invited to take part in a focus group to measure their training experience. Third, trained therapists will then deliver the hybrid CBT treatment to patients and pre- and post-outcome measures will be taken for single-case evaluation. Finally, patients who have received the hybrid CBT will be invited to provide feedback in interviews. This will help determine treatment experiences.

  • REC name

    West Midlands - Coventry & Warwickshire Research Ethics Committee

  • REC reference

    23/WM/0016

  • Date of REC Opinion

    27 Mar 2023

  • REC opinion

    Further Information Favourable Opinion